Form4insider filings, from the source

SEC Form 4 · accession 0000899243-19-002335

FATE THERAPEUTICS INC · FATE

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Amir Nashat
Director
Period of report
Jan 30, 2019
Accepted (ET)
Feb 1, 2019 · 5:02 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001434316

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Jan 30, 2019S51,224$14.1645D1,474,979ISee Footnote
Common StockF1,F3Jan 30, 2019S990$14.1645D1,473,989ISee Footnote
Common StockF1,F4Jan 30, 2019S340$14.1645D1,473,649ISee Footnote
Common StockF1,F5Jan 30, 2019S463$14.1645D1,473,186ISee Footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses